Position in IDYA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,702,249
-$4,536,263 QoQ
Shares Held
111,112
-53.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.72931816545469.ToString("F0")%
None 2.2706818345453237.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. IDYA ranks #90 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in IDYA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,702,249 | 111,112 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $8,238,512 | 238,314 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,379,370 | 124,196 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,765,299 | 83,982 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,162,454 | 70,968 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,456,956 | 56,691 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,897,790 | 154,602 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,561,630 | 129,924 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,106,647 | 298,693 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,746,761 | 217,728 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,831,403 | 290,267 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,384,084 | 229,110 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $265,208 | 19,316 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,983,308 | 109,153 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $185,946 | 12,463 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $172,926 | 12,531 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $142,895 | 12,770 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $300,155 | 12,697 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,173,219 | 242,182 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||